News & Updates

Show Multimedia Only

IL-23 inhibitors work best at preventing PsA development in psoriasis

17 Apr 2026 by

Patients with psoriasis appear to have the lowest risk of developing psoriatic arthritis (PsA) when they are treated with IL-23 inhibitors than with other immunomodulatory agents, according to a real-world study.

IL-23 inhibitors work best at preventing PsA development in psoriasis

17 Apr 2026

Hydroxychloroquine treatment does not prevent RA onset in at-risk individuals

15 Apr 2026

In individuals at risk of rheumatoid arthritis (RA), 12 months of treatment with hydroxychloroquine falls short of preventing the development of the disease, according to the results of a phase II trial.

Hydroxychloroquine treatment does not prevent RA onset in at-risk individuals

15 Apr 2026

ACS patients with SLE require greater healthcare use

13 Apr 2026

Systemic lupus erythematosus (SLE) patients with acute coronary syndrome (ACS) need a longer hospital stay and accrue higher charges, resulting in higher healthcare utilization, reports a study.

ACS patients with SLE require greater healthcare use

13 Apr 2026

Early onset, recurrent illness tied to DADA2 disease damage

13 Apr 2026

In patients with deficiency of adenosine deaminase 2 (DADA2) vasculitis, early age of onset and periodic illness are associated with disease-related damage, but prompt initiation of a tumour necrosis factor inhibitor (TNFi) may prevent complications and severe progression, suggests a study.

Early onset, recurrent illness tied to DADA2 disease damage

13 Apr 2026

LEVI-04 improves knee osteoarthritis outcomes

13 Apr 2026

Treatment with LEVI-04—a p75 neurotrophin receptor (p75NTR) fusion protein that inhibits neurotrophin-3—helps improve pain and function in patients with knee osteoarthritis, as shown in a phase II trial.

LEVI-04 improves knee osteoarthritis outcomes

13 Apr 2026

Genes affect response to COVID-19 vax, standard vaccination approach appropriate for SAD patients

11 Apr 2026 by

Genetic markers, both in and outside the immune system, influence an individual’s response to the SARS-CoV-2 vaccine, and these effects are similar in patients with or without systemic autoimmune diseases (SADs), reports a study.

Genes affect response to COVID-19 vax, standard vaccination approach appropriate for SAD patients

11 Apr 2026

Close relatives of Sjögren’s disease patients also at increased risk of cancer

06 Apr 2026

Patients with Sjögren’s disease (SjD) have a heightened risk of cancer, and this risk increase extends to their first-degree relatives, according to a study.

Close relatives of Sjögren’s disease patients also at increased risk of cancer

06 Apr 2026

ICONIC-ADVANCE 1-year data herald a shift in plaque psoriasis treatment

06 Apr 2026 by

Data from two phase III ICONIC-ADVANCE studies presented at AAD 2026 reinforce the potential of the investigational first-in-class targeted oral peptide icotrokinra for the treatment of plaque psoriasis (PsO).

ICONIC-ADVANCE 1-year data herald a shift in plaque psoriasis treatment

06 Apr 2026

What are the risk factors for peritonitis in SLE patients undergoing dialysis?

28 Mar 2026

For patients with systemic lupus erythematosus (SLE) who are undergoing peritoneal dialysis, the risk of peritonitis development may increase with the use of gastric acid suppressants and glucocorticoids and in males, according to a retrospective study.

What are the risk factors for peritonitis in SLE patients undergoing dialysis?

28 Mar 2026

Gout not a risk factor for dementia

17 Mar 2026

Gout does not contribute to an increased risk of overall dementia and may even be protective against Alzheimer's disease (AD) and cognitive impairment, according to the results of a systematic review and meta-analysis.

Gout not a risk factor for dementia

17 Mar 2026

News & Updates

Showing Rheumatology articles

Showing

Specialty:

IL-23 inhibitors work best at preventing PsA development in psoriasis

IL-23 inhibitors work best at preventing PsA development in psoriasis

Hydroxychloroquine treatment does not prevent RA onset in at-risk individuals

Hydroxychloroquine treatment does not prevent RA onset in at-risk individuals

ACS patients with SLE require greater healthcare use

ACS patients with SLE require greater healthcare use

Early onset, recurrent illness tied to DADA2 disease damage

Early onset, recurrent illness tied to DADA2 disease damage

LEVI-04 improves knee osteoarthritis outcomes

LEVI-04 improves knee osteoarthritis outcomes

Genes affect response to COVID-19 vax, standard vaccination approach appropriate for SAD patients

Genes affect response to COVID-19 vax, standard vaccination approach appropriate for SAD patients

Close relatives of Sjögren’s disease patients also at increased risk of cancer

Close relatives of Sjögren’s disease patients also at increased risk of cancer

ICONIC-ADVANCE 1-year data herald a shift in plaque psoriasis treatment

ICONIC-ADVANCE 1-year data herald a shift in plaque psoriasis treatment

What are the risk factors for peritonitis in SLE patients undergoing dialysis?

What are the risk factors for peritonitis in SLE patients undergoing dialysis?

Gout not a risk factor for dementia

Gout not a risk factor for dementia